[Form 3] Colgate-Palmolive Company Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Colgate-Palmolive (NYSE: CL) submitted a routine Form 3 – Initial Statement of Beneficial Ownership for newly reported insider John Hazlin, Chief Growth Officer.

The filing shows Hazlin directly owns 14,385 common shares and indirectly owns 5,382 shares through the company’s 401(k) plan, for a total of 19,767 shares of common stock. In addition, he holds five separate stock-option grants covering an aggregate 103,340 underlying shares with exercise prices ranging from $72.83 to $106.34 and expiration dates between 2028 and 2032. Vesting schedules are disclosed for each grant, generally becoming exercisable in one-third increments starting one year after the grant date.

No purchases, sales or other transactions occurred on the reported event date (06/16/2025); the form simply establishes Hazlin’s beneficial ownership under Section 16(a). The filing contains no financial results, strategic updates, or other material corporate events.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hazlin John

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/16/2025

3. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Growth Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	14,385	D
Common Stock	5,382	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	09/13/2031	Common Stock	19,342	$72.83	D
Stock Option (Right to Buy)	(2)	09/10/2028	Common Stock	20,989	$76.41	D
Stock Option (Right to Buy)	(3)	09/10/2029	Common Stock	23,376	$77.04	D
Stock Option (Right to Buy)	(4)	09/09/2030	Common Stock	22,944	$78.03	D
Stock Option (Right to Buy)	(5)	09/12/2032	Common Stock	16,689	$106.34	D

Explanation of Responses:

1. Option became exercisable in one-third increments beginning on the first anniversary of the September 13, 2023 grant date.

2. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.

3. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2021 grant date.

4. Option became exercisable in one-third increments beginning on the first anniversary of the September 9, 2022 grant date.

5. Option becomes exercisable in one-third increments beginning on the first anniversary of the September 12, 2024 grant date.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Kristine Hutchinson, Attorney-in-Fact	06/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Colgate-Palmolive shares does Chief Growth Officer John Hazlin own?

According to the Form 3, Hazlin owns 19,767 common shares—14,385 held directly and 5,382 held indirectly via the company’s 401(k) plan.

What stock-option grants were reported for [[CL]]’s John Hazlin?

The filing lists five option grants covering 103,340 shares with exercise prices from $72.83 to $106.34, expiring 2028-2032.